Buy 5-Meo-DMT Online
Buy 5-Meo-DMT Quality Online or 5-methoxy-N,N-dimethyltryptamine is a ring-substituted indole alkaloid molecule of the tryptamine class. Tryptamines share a core structure comprised of a bicylic indole heterocycle
5-MeO-DMT or 5-methoxy-N,N-dimethyltryptamine is a ring-substituted indole alkaloid molecule of the tryptamine class.
Tryptamines share a core structure comprised of a bicylic indole heterocycle attached at R3 to a terminal amine group via an ethyl side chain.
it also contains two methyl groups CH3- bound to the terminal amine RN of its tryptamine backbone (DMT). 5-MeO-DMT is the N-substituted methyl homologue of 5-MeO-MiPT, although it radically differs in its effects.
In a survey study of 362 adults, Davis found that when administered in a ceremonial group setting with a knowledgeable facilitator, approximately 80 percent of people said that their depression or anxiety is improved following the use of 5-MeO-DMT.
According to Davis, this is likely because of the type of “mystical” experience one has on the drug trip, which allows the person to gain new, novel insight into themselves or their relationships through a shift in consciousness.
“This information, these experiences, seem to be really powerful and profound and they seem to help people to change, and to make different choices in their life,” says Davis.
Interestingly, this fits in with research on other psychedelic substances such as psilocybin, which has also been found to have significant anti-depression and anti-anxiety effects. One of the major downsides to the potential use of psilocybin in a clinical setting is that the psychedelic experience lasts four to six hours. Tacking on an extra hour before to get ready and after to ensure the patient is ready to be discharged, psilocybin would mean a whole day of treatment. That will add up to a very expensive session if it is eventually approved for public use, according to Davis.
“One of the interesting things about 5-Meo-DMT is that the duration of effect is anywhere from 20 to 60 minutes,” says Davis. “You can start to imagine a world where if this was a medication, you could actually have someone there for more of a standard psychotherapy time frame and have an entire psychedelic healing experience.”
Because this treatment could more easily be scaled into our current mental health care, it would likely be more accessible to people who might benefit from the treatment. Currently, Davis is working with a larger team on creating a clinical trial with the aim to eventually look at the administration of the drug in a laboratory setting.
Although Davis’s team has heard of potential risks involved with use of the drug, in part because of instances of it being mis-administered, he says that the data indicates that in the right setting where facilitators pay proper attention to people’s well-being, users are having mostly positive experiences.